This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
While this report hit the virtual bookshelf about six months ago, I am revisiting it on this first day of the second quarter of 2025 because of its salience in this moment of uncertainties across our professional and personal lives — particularly related to health politics, global economics and trade, and the erosion of trust in institutions.
After subsequent due diligence and final cohort selection in May, the 2025 accelerator will commence at the invite-only Innovator Summit June 25-26, where 125 startups from all the Innovator cohorts will convene in Mountain View, California, to engage with hundreds of representatives from MTIs partners, mentors and alumni.
About SWK Holdings SWK Holdings is a lifescience-focused specialty finance company partnering with small- and mid-sized commercial-stage healthcare companies. SWK provides non-dilutive financing to fuel the development and commercialization of lifesaving and life-enhancing medicaltechnologies and products.
A shortage of doctors in countries such as China is also spurring demand for new AI tools to analyze medical images and the race is on to commercialize products that could shake up health care systems around the world. The size of the global medical imaging analytics software market is also expected to jump to $4.3
The following is a guest article by Abhishek Khandelwal, Vice President, LifeSciences at Capgemini Engineering The convergence of digital technology and healthcare has been underway for quite some time, but as we inch closer to 2024, the pace of change that this sector is experiencing is unprecedented.
The organisation’s vision is to leverage Australia’s existing strengths in health and medical research, medicaltechnology and healthcare delivery into the creation of a world-leading, national, integrated ecosystem for the development, commercialisation and implementation of evidence-based digital health technologies in Australia.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content